Strength
.03 mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065859502
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC; TOPICAL
Last Updated
4/22/2026
Active Ingredients
ACOLTREMONApproval Type
New Drug (NDA)
FDA Application
NDA217370On Market Since
7/23/2025
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.